
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

